Sleep, meal timing and glucose monitoring in early pregnancy and gestational diabetes
Tests wearable self-monitoring of sleep, meals and glucose in pregnant women without diabetes.
Key facts
- Who runs it
- KK Women's and Children's Hospital
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY
- Status
- Recruiting
- People taking part
- 140 people, planned
- Started
- 1 May 2026
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Continuous glucose monitor (CGM)
- Wrist actigraphy device
- AI-based dietary and meal timing logging mobile application
- Record updated
- 15 September 2026
Who can take part
The trial is looking for women in early pregnancy, without diabetes, who are already in the TOFFFY study. It looks at how sleep, activity and meal timing relate to blood sugar.
- Age
- 21 Years to 39 Years
- Sex
- Female only
- Disease stage
- A healthy pregnancy growing inside the womb, at ≤13 weeks of pregnancy at enrolment. Only one baby.
- Earlier treatment
- People taking medicines known to strongly affect blood sugar cannot join.
- Main reasons for not taking part
- Diabetes before pregnancy (Type 1 or Type 2)
- Long-term health problems that affect blood sugar
- Taking medicines known to strongly affect blood sugar
- Pregnancy with twins or more babies
- Unable to use smartphone apps or wear a wrist activity device
This trial only enrols pregnant participants. The registry sentence this rests on: * Females who are currently pregnant and with viable intrauterine pregnancy at ≤13 weeks gestation at enrolment
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Enrolled in the Towards Optimal Fertility, Fathering and Fatherhood studY (TOFFFY) (NCT06293235)
- Females who are currently pregnant and with viable intrauterine pregnancy at ≤13 weeks gestation at enrolment
Who cannot take part
- Females with pre-existing diabetes mellitus (Type 1 or Type 2) and/or chronic medical conditions affecting glucose metabolism
- Females who are taking medications known to significantly affect glucose metabolism
- Females with multiple pregnancy (e.g., twins or higher-order gestation)
- Females who are unable to comply with study procedures, including: Inability to use smartphone-based applications and inability to wear wrist actigraphy device
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
This trial is currently available in Singapore.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to examine how daily behavioral patterns in early pregnancy, including sleep, physical activity, and meal timing, influence continuous glucose dynamics and subsequent risk of gestational diabetes mellitus (GDM) in pregnant women without pre-existing diabetes.
Read full original descriptionShow less
The main questions it aims to answer are:
1. Do early-pregnancy chronobehavioral patterns (e.g., irregular sleep, night eating, and unstable rest-activity rhythms) relate to continuous glucose patterns measured using continuous glucose monitoring (CGM)? 2. Can early behavioral and CGM-derived measures predict glucose regulation and metabolic outcomes later in pregnancy (24-28 weeks)? 3. Does real-time self-monitoring using wearable devices and food logging improve glycemic outcomes compared to usual care?
This study is a prospective, nested randomized pilot trial embedded within the ongoing Towards Optimal Fertility, Fathering and Fatherhood studY (TOFFFY) cohort (NCT06293235) at KK Women's and Children's Hospital, Singapore. A total of 140 pregnant women without pre-existing diabetes, recruited at ≤13 weeks gestation, will be randomized in a 1:1 ratio to either a pilot arm (wearable-based self-monitoring) or a control arm (usual care).
Participants in the pilot arm (n=70) will undergo intensive behavioral and metabolic monitoring over a 14-day period in early pregnancy, including continuous glucose monitoring using a CGM device, wrist actigraphy to assess sleep-wake and rest-activity patterns, and an AI-supported mobile application to record meal timing and dietary intake. Participants will have real-time access to their glucose data and behavioral feedback, enabling self-monitoring and potential behavioral adjustments.
The 2 groups in the trial
- Pilot armTreatment being tested
Participants in this arm (n=70) will undergo a 14-day monitoring period in early pregnancy (≤13 weeks gestation). Participants will have real-time access to their glucose data and food logging feedback, enabling self-monitoring and potential behavioural adjustments. Participants will also continue to receive routine antenatal care and standard clinical assessments.
Treatment: Continuous glucose monitor (CGM), Wrist actigraphy device, and AI-based dietary and meal timing logging mobile application
- Control ArmNo study treatment, for comparison
Participants (n=70) receive routine antenatal care only, with no additional devices, monitoring, or feedback introduced by the study.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early-Pregnancy Chronobehavioural Profiles and Continuous Glucose Dynamics: A Nested Randomised Pilot Study of TOFFFY
- Plain-language title
- Sleep, meal timing and glucose monitoring in early pregnancy and gestational diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07534670, who can take part
- Record updated
- 15 September 2026